ANTX · AN2 Therapeutics, Inc. · Documents
$3.60
+0.04 (+1.12%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$142.08M
Shares
37.74M
Volume · Oct 21
177.37K
Avg daily vol (3M)
249.97K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2023-11-09 | 2023-09-30 | |
| 8-K | — | 2023-11-09 | — | |
| 8-K | — | 2023-09-13 | — | |
| 8-K | — | 2023-09-08 | 2023-09-01 | |
| 8-K | — | 2023-08-16 | 2023-08-15 | |
| 8-K | — | 2023-08-10 | — | |
| 10-Q | — | 2023-08-10 | 2023-06-30 | |
| 8-K | — | 2023-06-09 | 2023-06-07 | |
| 8-K | — | 2023-05-11 | — | |
| 10-Q | — | 2023-05-11 | 2023-03-31 | |
| DEF 14A | — | 2023-04-26 | 2023-06-07 | |
| DEFA14A | — | 2023-04-26 | — | |
| ARS | — | 2023-04-26 | 2022-12-31 | |
| S-3 | — | 2023-04-06 | — | |
| 8-K | — | 2023-03-29 | — | |
| 10-K | — | 2023-03-29 | 2022-12-31 | |
| 10-Q | — | 2022-11-09 | 2022-09-30 | |
| 8-K | — | 2022-11-09 | — | |
| 8-K | — | 2022-10-06 | — | |
| 8-K | — | 2022-08-11 | — | |
| 10-Q | — | 2022-08-11 | 2022-06-30 | |
| 8-K | — | 2022-06-29 | — | |
| 8-K | — | 2022-05-10 | — | |
| 10-Q | — | 2022-05-10 | 2022-03-31 | |
| 8-K | — | 2022-05-09 | 2022-05-05 | |
| S-1/A | — | 2022-03-21 | — | |
| S-1 | — | 2022-03-04 | — |
Showing 51–77 of 77 filings